Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Browse >  Disease/Condition

NGC Browse - Disease/Condition Results

Mental Disorders - List all 191 guidelines
Substance-Related Disorders - List all 63 guidelines
Opioid-Related Disorders - List all 15 guidelines

Display results 1 to 14 of 14
Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2004. 171 pages. NGC:003873
Medication-assisted treatment for opioid addiction in opioid treatment programs: Approaches to providing comprehensive care and maximizing patient retention. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 22 pages. NGC:004675
Medication-assisted treatment for opioid addiction in opioid treatment programs: Associated medical problems in patients who are opioid addicted. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 18 pages. NGC:004677
Medication-assisted treatment for opioid addiction in opioid treatment programs: Clinical pharmacotherapy. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 23 pages. NGC:004672
Medication-assisted treatment for opioid addiction in opioid treatment programs: Drug testing as a tool. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 17 pages. NGC:004676
Medication-assisted treatment for opioid addiction in opioid treatment programs: Initial screening, admission procedures, and assessment techniques. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 19 pages. NGC:004663
Medication-assisted treatment for opioid addiction in opioid treatment programs: Medication-assisted treatment for opioid addiction during pregnancy. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 14 pages. NGC:004680
Medication-assisted treatment for opioid addiction in opioid treatment programs: Patient treatment matching: Types of services and levels of care. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 14 pages. NGC:004673
Medication-assisted treatment for opioid addiction in opioid treatment programs: Phases of treatment. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 20 pages. NGC:004674
Medication-assisted treatment for opioid addiction in opioid treatment programs: Treatment of co-occurring disorders. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 21 pages. NGC:004679
Medication-assisted treatment for opioid addiction in opioid treatment programs: Treatment of multiple substance use. Substance Abuse and Mental Health Services Administration (U.S.) - Federal Government Agency [U.S.]. 2005. 10 pages. NGC:004678
Methadone and buprenorphine for the management of opioid dependence. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 37 pages. NGC:005506
Naltrexone for the management of opioid dependence. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 28 pages. NGC:005507
Substance misuse and alcohol use disorders. In: Evidence-based geriatric nursing protocols for best practice. Hartford Institute for Geriatric Nursing - Academic Institution. 2008. 27 pages. NGC:006333

Heroin Dependence - 2 guidelines


Search Help
Detailed Search
Frequent Searches